ArticleThe Journal of clinical endocrinology and metabolism2010

Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression.

Zachary M Bush et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.